Showing results (151-160 of 203) with videos related to
Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry|November 3, 2004
Synthesis and biological evaluation of 5R- and 5S-methyl substituted D- and L-configuration 1,3-dioxolane nucleoside analogsSanjib Bera, Leila Malik, Balkrishen Bhat, et al.Hepatology (Baltimore, Md.)|August 8, 2014
Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirinCharlotte Hedskog, Brian Doehle, Krishna Chodavarapu, et al.The Journal of Infectious Diseases|November 26, 2015
L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B SubstitutionsEvguenia S Svarovskaia, Edward Gane, Hadas Dvory-Sobol, et al.AIDS (London, England)|February 10, 2018
Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trialsKirsten White, Will Garner, Lilian Wei, et al.The Journal of Biological Chemistry|December 14, 2002
Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acidCathryn A Shaw-Reid, Vandna Munshi, Pia Graham, et al.The Journal of Infectious Diseases|December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failureJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.The Journal of Biological Chemistry|October 15, 2010
Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leadsMichael J Caulfield, Vadim Y Dudkin, Elizabeth A Ottinger, et al.Plos Pathogens|February 4, 2010
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cellsNichole R Klatt, Emi Shudo, Alex M Ortiz, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2007
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled studyMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.Antimicrobial Agents and Chemotherapy|March 27, 2013
Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitnessMichael E Abram, Rebecca M Hluhanich, Derrick D Goodman, et al.Pageof 21